AUG 10, 2026 · PHASE 1 TRIAL
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
ClinicalTrials.gov
This is a Phase 1 trial registration with no results posted; it describes planned enrollment and safety endpoints only, without outcome data.
Reported
Planned enrollment42
Trial phasePHASE 1
Primary outcome measure (Part 1)Incidence of dose limiting toxicities, up t…